About Zydus Gefitinib Tablets IP 250 Mg
Secure a rarefied solution for advanced cancer care with Zydus Gefitinib Tablets IP 250 Mg. Designed for flawless oral administration, these film-coated, light brown tablets are embossed for unmistakable identification and arrive in a blister-packed carton of 30 pieces per box. Instantly customizable as prescribed by your physician, this towering therapeutic option is indicated for adults with locally advanced or metastatic NSCLC harboring EGFR mutations. Get It Now with Instant Checkout-trusted antineoplastic efficacy backed by stringent Indian origin and rigorous quality standards.
Elite Features & Professional Use
Zydus Gefitinib Tablets IP 250 Mg stands out for its precise film-coated design, rare packaging integrity, and unmistakable quality. Recommended for adults, it is predominantly prescribed by oncology specialists for patients battling non-small cell lung cancer. The flawless 250 mg dosage, embossing, and stringent storage requirements ensure both safety and efficacy. Its towering clinical value is complemented by detailed patient advice on monitoring, making it indispensable for advanced therapeutics.
Sample Access & Secure Purchase Advantages
Experience the reliability of Zydus Gefitinib with accessible sample options and transparent rate structures for distributors and suppliers. Enjoy secure shipping and efficient logistics, ensuring products reach their main domestic market across India promptly. Payment terms are flexible to accommodate different business needs, supporting seamless procurement and fostering trust for pharmacies, traders, and healthcare facilities looking for trustworthy anticancer medication partners.
FAQ's of Zydus Gefitinib Tablets IP 250 Mg:
Q: How should Zydus Gefitinib Tablets IP 250 Mg be taken for optimal effectiveness?
A: Take one 250 mg tablet orally once daily at the same time, with or without food. Always follow your physician's specific dosage instructions for the best therapeutic outcome.
Q: What are the main benefits of choosing Zydus Gefitinib for NSCLC treatment?
A: Zydus Gefitinib provides a targeted approach as an EGFR tyrosine kinase inhibitor, enabling precise treatment for patients with advanced non-small cell lung cancer, especially those with EGFR mutations.
Q: When should patients consult their healthcare provider during Gefitinib use?
A: If you experience skin reactions, diarrhea, difficulty breathing, or signs of liver problems, contact your physician promptly. Routine monitoring, including periodic liver function tests, is strongly recommended.
Q: Where is Zydus Gefitinib manufactured and distributed?
A: Zydus Gefitinib is manufactured in India and widely distributed across the country by authorized pharmaceutical suppliers, traders, and distributors.
Q: What precautions or storage conditions should be followed with this medication?
A: Store Zydus Gefitinib tablets in a cool, dry place below 30C, protected from moisture and light to maintain their flawless efficacy and shelf life for up to 24 months.
Q: How can I place an order or get a product sample?
A: Orders and sample requests can be made through authorized distributors or suppliers. Instant Checkout and secure shipping options are available for a seamless procurement process.